Abstract
This study was made to test the clinical significance and the prognostic value of the T-B immunological classification of non-Hodgkin's lymphomas. Thirty-four patients with adult diffuse lymphomas were studied. Nine patients with T-cell lymphomas and three patients with non-T and non-B lymphomas had poor immunity and poor prognosis. Fifteen patients with B-cell lymphomas have been found to be associated with a prognosis of intermediate range between that of T-cell lymphomas and undetermined lymphomas. Seven patients with undetermined lymphomas, which were considered to have lost surface markers of B-cells, had the best prognosis. Thus the T-B immunological classification of this disorder appears to be essential for clinicians, and provides a basis for proper differentiation of treatment for different groups.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
